-deoxycytidine adducts to the stable N 
cated in the initiation of mutagenic and carcinogenic template containing a single N 3 -(2-hydroxyethyl)deoxyuridine, the adduct blocked DNA replication by the events (reviewed in 1, 2) . While the majority of genotoxic agents react most readily with guanine resi-Klenow fragment of E. coli and bacteriophage T7 polymerase in vitro (17). In the absence of proofreading dues, some extensively target one or more of the other bases (3 -6) .
functions, the lesion could be bypassed and both A and T were incorporated opposite the adduct, resulting in BM, 3 a known mutagen (7) and carcinogen in mouse skin painting studies (8), has been shown to induce GC r AT and GC r TA mutagenesis. Understanding the factors involved in these alkylation and deaminamutations at both GC and AT base pairs (7) , suggesting that any of the four nucleoside bases of DNA may be tion reactions is important for understanding of the DNA interactions of chemical carcinogens. involved in BM-induced mutation and carcinogenesis. We have previously identified eight adducts formed in
In this study we report the characterization of the adducts formed by the reaction between deoxycytidine the reaction of guanosine with BM (9). These adducts were characterized as diastereomeric N 1 -(1-hydroxy-and racemic BM. We find that alkylation of deoxycytidine at the N 3 position results in deamination of deoxy-3-buten-2-yl)guanosine, N 2 -(1-hydroxy-3-buten-2-yl)-guanosine, N 7 -(1-hydroxy-3-buten-2-yl)guanosine, and cytidine to deoxyuridine. The pseudo-first-order kinetic rate constants of formation, stability, and effect of BM N 7 -(2-hydroxy-3-buten-1-yl)guanosine. While the N 1 -and N 2 -guanosine adducts were formed 10-fold less fa-concentration on adduct formation were examined.
Preliminary reports of these results have been prevorably than the N 7 -guanosine adducts, they were stable for up to 1 week while the N 7 adducts had half-sented (18). lives ranging from 48 to 96 h. Ten adducts formed in the reaction between adenosine with BM were also MATERIALS AND METHODS characterized (10). These adducts were characterized -(2-hydroxy-3-with a screw-top Teflon-coated cap until dissolved. An excess of BM buten-1-yl)adenosine diastereomers were formed only (0.16 ml; 2.0 mmol) was added and the reactions were heated at 50ЊC 2-fold less favorably than the individual N 7 -guanosine in a Dubnoff shaking water bath for 3 h (C-1, C-2, and C-3) or 24 h (C-4, C-5, C-6, and C-7). After removing reaction mixtures from the adducts.
water bath, they were cooled to room temperature and extracted four Cytosine contains multiple nucleophilic sites which times with 4 vol ethyl ether to remove unreacted BM. Reaction of may react with alkylating agents. In addition, cytosine deoxycytidine with BM in H 2 O for 3 h produced two major peaks (Cis susceptible to deamination into uridine, a base not 1 and C-2), in addition to starting material, separated by HPLC. naturally found in DNA, which has base pairing prop-Extension of this reaction to 24 h resulted in four later-eluting peaks by HPLC separation (C-4, C-5, C-6, and C-7). Reaction of deoxycytierties different from cytosine. This deamination reacdine with BM in glacial acetic acid for 3 h produced a major peak tion appears to be enhanced by alkylation of deoxycyti- duct (11) and propylene oxide-induced DNA adducts HPLC separations and purification were performed as previously cause both transition and transversion mutations at described for the guanosine and adenosine adducts of BM (9, 10).
Briefly, analytical separations were performed with a 20-ml injection cytosine residues when transfected into Escherichia -deoxyuridine adduct and, in a DNA system equipped with a diode array detector and UV detection at 260 and 280 nm. HPLC analysis involved use of a linear gradient program starting at 8 min from 10 to 100% pump B over 5 min [pump 3 Abbreviations used: BM, butadiene monoxide; ACN, acetonitrile; A 1% ACN (pH 2.5); pump B 10% ACN (pH 2.5)], at a flow rate of 1 ml/min. Semipreparative HPLC was performed using an isocratic FAB/MS, fast atom bombardment-mass spectrometry; C-1 and C-2, diastereomeric N 3 -(2-hydroxy-3-buten-1-yl)deoxycytidine; C-3, dia-solvent system pumping 75% B using a 100-ml injection volume on a Beckman Ultrasphere 5-mm ODS reverse-phase semipreparative stereomeric O reactions of deoxycytidine with BM whose retention times on a typical analytical chromatogram were 18.5, 19.3, 21.1, 23.2, 23.5, 24.2, and 25.0 min. These peaks were named C-1, C-2, C-3, C-4, C-5, C-6, and C-7 in order of their retention times, respectively. All adducts were fractionated two to four times by semipreparative HPLC until they were isomerically pure by analytical HPLC. The purified adducts were then used to obtain standard curves (r were greater than 0.99). The limits of detection using the analytical HPLC method were 0.5 mg/ml for N 3 -deoxycytidine and N 3 -deoxyuridine adducts and 1 mg/ml for O 2 -deoxycytidine adducts. Identification of BM-deoxycytidine adducts. UV spectra at pH 2.5 were performed using a Beckman diode array detector. Positive ion FAB/MS were performed using a Kratos MS-50 ultrahigh-resolution mass spectrometer as described previously (10 -(1-hydroxyas an internal standard. Circular dichroism spectra were recorded 3-buten-2-yl)deoxyuridine. The peak eluting at 10.7 min was also at 25ЊC on an Aviv circular dichroism spectrometer, Model 62A DS, present in the deoxycytidine control. using a 1-cm pathlength and an adduct concentration of 3 1 10
Deoxyuridine (10 mM) was reacted with BM (750 mM) in phosphate buffer (pH 7.4) at 37ЊC for 4 h in order to compare UV spectra and retention times of the products to products identified as BM-deoxy-HPLC. These products were designated C-1, C-2, C-3, uridine adducts from the reaction of deoxycytidine with BM.
C-4, C-5, C-6, and C-7 in order of their retention times To characterize the stability of the adducts, mixtures of all seven ( Fig. 1 ). All seven adducts were characterized by comadducts (prepared by lyophilization of reaction mixtures) were disparisons of the retention times and UV spectra to adsolved in 2 ml of 0.1 N HCl, 0.1 N NaOH, or water and stabilities were monitored at 24ЊC by HPLC analysis. Aliquots were withdrawn ducts prepared under synthetic conditions, which were at intervals, pH was adjusted to neutrality with 1 N HCl or 1 N also characterized by analysis of their 1 H NMR and NaOH, and they were immediately analyzed by HPLC for the disap-FAB/MS spectra. Protons were assigned to NMR sigpearance of the parent adduct peaks.
nals by comparing chemical shifts, multiplicities, inteAdduct stability at 37ЊC in phosphate buffer (pH 7.4) was examined gration ratios, and the results of homonuclear decouwith purified adduct (0.3 mM). Samples were withdrawn at timed intervals and analyzed by HPLC for disappearance of the parent pling experiments with the published spectra of the adduct peak.
characterized BM-guanosine and BM-adenosine ad-
The reaction of BM with deoxycytidine under physiologic condiducts (9, 10). Spectra of cytidine (19), 2-deoxycytidine, tions. Adduct formation under in vitro physiologic conditions (37ЊC, and 3-buten-1,2-diol were also used as references (data pH 7.4) was investigated. Deoxycytidine (3.1 or 9.6 mM) and BM (750 not shown). Products C-1 and C-2, C-4 and C-5, and mM) were reacted in 100 mM phosphate buffer (pH 7.4) containing C-6 and C-7 have nearly identical 1 H NMR spectra, 100 mM potassium chloride in a shaking water bath at 37ЊC for 4 h to calculate a pseudo-first-order rate constant. Aliquots were with-respectively, suggesting they are diastereomeric pairs. drawn at intervals, extracted with ethyl ether to remove unreacted Spectra representing each regioisomer are shown in BM, and either incubated at 80ЊC for 1 h to convert the unstable N Table I. and C-5) or not incubated (C-1, C-2, C-3, C-6, and C-7). In the case C-4 and C-5 were determined to be diastereomers of where the unstable adducts were analyzed, the samples were stored at 0ЊC until immediately before analysis by HPLC. The storage at N 3 -(2-hydroxy-3-buten-1-yl)deoxyuridine based on the 0ЊC was found to prevent the decomposition and deamination of the following data. With a maxima of 263 nm (Fig. 3A) , the unstable adducts. Analysis for adduct formation was performed by UV spectra of C-4 and C-5 were consistent with the -(2-hydroxy-3-buten-2-yl)deoxycytidine, C-3. Peak numbers correspond to assignments in Fig. 4 . the adducts we have previously characterized with guanosine and adenosine (9, 10). Small differences in the shifts of H . The FAB/MS fragmentation patterns of C-6 and C-7 (Fig. 5B) were again very similar and are consistent with the proposed structure (Fig. 4) . The expected molecular ion of m/z 299 (M / 1) was present in both spectra, as was, again, the 183 fragment representing the loss of the sugar. In addition, there was a small fragment at m/z 165, and the sugar peak at m/z 117. Loss of the entire BM side chain from bH 2 with H transfer back to the ring gave m/z 113.
The CD spectra of the N 3 -deoxyuridine adducts (Figs. 3B and 3C) exhibit similar overall shapes, with the diastereomeric pairs demonstrating significant differences in magnitude and shape at certain wavelengths. These results suggest that the CD spectra of the adducts were dominated by the uridine ring chromophore rather than on the BM moiety containing the chiral center of interest. However, these differences are consistent with diastereomeric separation.
Further evidence for the characterization of C-4, C-5, C-6, and C-7 as deoxyuridine adducts was obtained shape and maxima of other N 3 -substituted cytidine adducts (20) , and distinct from the N 3 -deoxyuridine adThe FAB/MS fragmentation patterns of C-4 and C-5 were very similar and are consistent with the proposed ducts described above. When incubated at room temperature or higher, purified adducts C-1 and C-2 were structure (Fig. 4) . The expected molecular ion of m/z 299 (M / 1) was present in both spectra (Fig. 5A) , as unstable and converted to peaks with retention times and UV spectra consistent with peaks C-4 and C-5, was the m/z 183 fragment which represents the typical nucleoside fragmentation to bH 2 , loss of the sugar respectively. This suggested C-1 and C-2 are N 3 -deoxycytidine adducts that undergo hydrolytic deamination peak. Also present were the fragments m/z 165, corresponding to loss of H 2 O from bH 2 , and the sugar peak, to N 3 -deoxyuridine adducts. Previous studies have also found that N 3 -deoxycytidine adducts readily deaminate m/z 117.
C-6 and C-7 were determined to be diastereomers of to N 3 -deoxyuridine adducts (11-15). NMR spectra performed in D 2 O suggested that the BM moiety is N 3 -(1-hydroxy-3-buten-2-yl)deoxyuridine based on the following data. With a maxima of 263 nm (Fig. 3A) , attached to the N 3 of deoxycytidine at the terminal carbon based upon the shift of H 7 (Fig. 2, Table I ), and the UV spectra of C-6 and C-7 are consistent with the spectral shape and maxima of the C-4 and C-5 regio-this assignment was confirmed by the deamination to C-4 and C-5, the N 3 -deoxyuridine adducts attached at isomers, and other N 3 -substituted uridine adducts (20) . NMR of both diastereoisomers suggested that the BM the terminal carbon. The shift of H 7 was similar in C-1, C-2, C-4, and C-5 (4.60, 4.60, 4.46, and 4.45 ppm, moiety is attached to the N 3 of deoxyuridine at the carbon adjacent to the double bond based on the shift respectively), while H 7 was shifted farther upfield in C-6 and C-7 (5.55 and 5.55 ppm, respectively). This of H 7 . As stated above, H 7 was shifted farther downfield in C-6 and C-7 (5.55 and 5.55 ppm) than in the regio-suggested that in C-1 and C-2, H 7 is also adjacent to
FIG. 4. BM reacts with deoxycytidine to form one O

2
-deoxycytidine regioisomer and two N 3 -deoxycytidine regioisomers which both undergo hydrolytic deamination to form the corresponding N pected molecular ion of m/z 298 (M / 1) was present in the spectra (Fig. 5D) , as was the m/z 182 fragment representing the bH 2 fragment also seen in C-1 and C-2, representing the loss of the sugar from m/z 298.
Stability of purified BM-deoxycytidine and BMdeoxyuridine adducts. O
2 -and N
3
-alkylated deoxycytidine can be further characterized by the lower stability of O 2 -alkylated deoxycytidine under acid and alkali conditions (23, 24). Incubation of all adducts in 0.1 N HCl, 0.1 N NaOH, or H 2 O confirmed the assignments made above. In 0.1 N HCl, C-1, C-2, C-4, C-5, C-6, and C-7 were stable for up to 96 h, while the peak C-3, corresponding to the O 2 -alkyldeoxycytidine, had decreased by 40% in 96 h at 24ЊC. In 0.1 N NaOH, all adducts were unstable; however, peak C-3 was completely absent by 1 h at 24ЊC, while C-4, C-5, C-6, and C-7 had half-lives of approximately 8.8 h (C-4 and C-5) and 6.3 h (C-6 and C-7), and C-1 and C-2 were the most stable adducts in 0.1 N NaOH with half-lives of approximately 24 h. In H 2 O, the N 3 -alkylated deoxyuridine adducts were completely stable, while C-1, C-2, and C-3 had half-lives of 29, 24, and 34 h, respectively.
Incubation of purified regioisomeric N 3 -deoxyuridine adducts (C-4, C-5, C-6, and C-7) at 37ЊC in phosphate buffer (pH 7.4) demonstrated that they were completely stable for 7 days (Fig. 6 ). The N 3 -deoxycytidine adducts of BM are unstable under physiologic -1 and C-2) resulted in conversion to the N 3 -(2-hydroxy-3-buten-1-yl)deoxyuridine adducts (C-4 and C-5, respectively) with half-lives of 2.3 and 2.5 h, respectively (Fig. 6 ). The N 3 -(1-hydroxy-3-buten-2-yl)deoxycytidine diastereomers were not detected, while the corresponding deoxyuridine adducts (C-6 and C-7) were, suggesting that the rate of deamination of this regioisomer was too rapid to detect. Thus the rate of hydrolytic deamination of these regioisomeric deoxycytidine adducts to deoxyuridine adducts occurs at different rates, possibly due to the involvement of the hydroxyl group of the alkylating agent in the deamination reaction as proposed by Solomon et al. (11) . We see a more rapid deamination event in the regioi- the hydroxyl group attached to the terminal carbon underwent deamination to the N 1 -inosine adduct; however, both the N 1 -a-and the N 1 -b-adenosine adhydroxy-3-buten-1-yl)deoxyuridine regioisomer formed ducts of styrene oxide deaminate with the primary 3.5-fold more favorably than the N 3 -(1-hydroxy-3-buhydroxyl-containing a-adduct deaminating at a 35-ten-2-yl)deoxyuridine isomer. These results suggest fold greater rate (22) .
that there is no threshold BM concentration for the The N 3 -deoxyuridine adducts could be important muformation of adducts with deoxycytidine near the range tagenic precursors because uridine is not a natural tested, and all of the adducts may be formed at lower component of DNA and base-pairs differently than cyti-BM concentrations even though they would be below dine. BM-induced GC r AT transition mutations have the limits of detection of our assay. been observed (8). The purified O 2 -deoxycytidine diaReaction of deoxycytidine (3.1 or 9.6 mM) with an stereomers (C-3) are also unstable at 37ЊC (pH 7.4) and unlimiting BM concentration (750 mM) under physiodealkylate with a half-life of 11 h, which may be long logic conditions (pH 7.4, 37ЊC) allowed calculation of enough to also be potentially mutagenic.
pseudo-first-order rate constants. C-3, C-6, and C-7 had Effect of BM concentration on the formation of ad-linear rates of formation throughout the 4-h study, ducts. A roughly linear formation of adducts was while C-1 and C-2, the N 3 -deoxycytidine diastereomers, found when deoxycytidine (10 mM) was reacted with were initially linear, but plateaued at later time points varying amounts of BM (10, 25, 50, and 500 mM) for 1 as they deaminated to C-4 and C-5 (Figs. 8A and 8B ). h in phosphate buffer (pH 7.4) at 37ЊC. When the 80ЊC Meanwhile, C-4 and C-5 demonstrated an initial lag in conversion step was included, the major N 3 -deoxyuri-formation which is probably due to the time needed for dine regioisomer adducts (C-4 and C-5) were detected deamination. C-6 and C-7 did not show similar lags in at all concentrations (Fig. 7) . The other regioisomer (C-formation possibly because the deamination event to 6 and C-7) was detected only at 50 and 500 mM BM. convert the N 3 -deoxycytidine adducts to N 3 -deoxyuriWhen no conversion step was included, the N 3 -deoxy-dine adducts is much faster and thus the precursor N 3 -cytidine adducts (C-1 and C-2) were detected all the deoxycytidine adducts are never observed. In this case, way down to 5 mM BM, the O 2 -deoxycytidine adducts C-1, C-2, C-3, C-6, and C-7 demonstrated linear formawere detected at 2.5-fold and higher concentrations of tion from 0 to 120 min (0 to 60 min for C-1 and C-2). BM, and N 3 -deoxyuridine adducts were detected at 5-Evidence that the reaction was occurring under fold and higher BM concentrations (data not shown). At pseudo-first-order conditions was demonstrated by a concentrations lower than those stated, adducts were similar rate constant calculation at both concentrations undetectable by this HPLC method because the of deoxycytidine, thus pseudo-first-order rate constants amounts of adducts were below the limits of detection. were calculated for the formation of each of these adThe ratios of adducts formed remained consistent over ducts. These rate constants were 6. 8C and 8D ) and should give rates of formation similar to the initial rates of C-1 and duced a slightly lower yield of adducts but was significantly above that for deoxyadenosine and thymidine. C-2 formation. These rate constants were 5.2 1 10 03 h 01 (C-4) and 7.2 1 10 03 h 01 (C-5). Rate constants for The reaction of 2-cyanoethylene oxide with deoxynucleosides also resulted in a similar reactivity of the nucleo-C-6 and C-7 with the conversion step were similar to sides (12). Deamination reactions similar to the one dethose calculated without the conversion step. Compariscribed here have previously been observed in the reacson of the rate constants for the reactions of BM with tion between several two-and three-carbon epoxides guanosine (9), adenosine (10), and deoxycytidine shows and deoxycytidine. These reactions usually form a single that, under in vitro physiologic conditions, the major N ducts deaminate to deoxyuridine adducts at different rates. In this regard, we believe our study is the first to SUMMARY characterize regioisomeric adducts of the epoxide ring Previous studies with other reactive epoxides have opening and observe a difference in the rate of deamination between the two. resulted in formation of deoxycytidine adducts. In a re-
